203 related articles for article (PubMed ID: 24057258)
41. The MLL fusion gene, MLL-AF4, regulates cyclin-dependent kinase inhibitor CDKN1B (p27kip1) expression.
Xia ZB; Popovic R; Chen J; Theisler C; Stuart T; Santillan DA; Erfurth F; Diaz MO; Zeleznik-Le NJ
Proc Natl Acad Sci U S A; 2005 Sep; 102(39):14028-33. PubMed ID: 16169901
[TBL] [Abstract][Full Text] [Related]
42. [Leukemogenic pathway of infant leukemia with MLL fusion].
Eguchi M
Rinsho Ketsueki; 2021; 62(7):809-819. PubMed ID: 34349066
[TBL] [Abstract][Full Text] [Related]
43. Establishment of MLL/AF4 transgenic mice with the phenotype of lymphoblastic leukemia or lymphoma.
Tamai H; Inokuchi K
J Nippon Med Sch; 2013; 80(5):326-7. PubMed ID: 24189350
[No Abstract] [Full Text] [Related]
44. Multistep pathogenesis of leukemia via the MLL-AF4 chimeric gene/Flt3 gene tyrosine kinase domain (TKD) mutation-related enhancement of S100A6 expression.
Yamaguchi H; Hanawa H; Uchida N; Inamai M; Sawaguchi K; Mitamura Y; Shimada T; Dan K; Inokuchi K
Exp Hematol; 2009 Jun; 37(6):701-14. PubMed ID: 19463771
[TBL] [Abstract][Full Text] [Related]
45. Prognostically significant fusion oncogenes in Pakistani patients with adult acute lymphoblastic leukemia and their association with disease biology and outcome.
Sabir N; Iqbal Z; Aleem A; Awan T; Naeem T; Asad S; Tahir AH; Absar M; Hasanato RM; Basit S; Chishti MA; Faiyaz Ul-Haque M; Khalid AM; Sabar MF; Rasool M; Karim S; Khan M; Samreen B; Akram AM; Siddiqi MH; Shahzadi S; Shahbaz S; Ali AS; Mahmood A; Akram M; Saeed T; Saleem A; Mohsin D; Shah IH; Khalid M; Asif M; Iqbal M; Akhtar T
Asian Pac J Cancer Prev; 2012; 13(7):3349-55. PubMed ID: 22994759
[TBL] [Abstract][Full Text] [Related]
46. miR-150 blocks MLL-AF9-associated leukemia through oncogene repression.
Bousquet M; Zhuang G; Meng C; Ying W; Cheruku PS; Shie AT; Wang S; Ge G; Wong P; Wang G; Safe S; Zhou B
Mol Cancer Res; 2013 Aug; 11(8):912-22. PubMed ID: 23604034
[TBL] [Abstract][Full Text] [Related]
47. Cryptic splice site activation during RNA processing of MLL/AF4 chimeric transcripts in infants with t(4;11) positive ALL.
Divoky V; Trka JM; Watzinger F; Lion T
Gene; 2000 Apr; 247(1-2):111-8. PubMed ID: 10773450
[TBL] [Abstract][Full Text] [Related]
48. Acute megakaryoblastic leukemia in a child with the MLL-AF4 fusion gene.
Takita J; Motomura A; Koh K; Ida K; Taki T; Hayashi Y; Igarashi T
Eur J Haematol; 2009 Aug; 83(2):149-53. PubMed ID: 19459927
[TBL] [Abstract][Full Text] [Related]
49. Rationale for targeting BCL6 in
Hurtz C; Chan LN; Geng H; Ballabio E; Xiao G; Deb G; Khoury H; Chen CW; Armstrong SA; Chen J; Ernst P; Melnick A; Milne T; Müschen M
Genes Dev; 2019 Sep; 33(17-18):1265-1279. PubMed ID: 31395741
[TBL] [Abstract][Full Text] [Related]
50. Down-regulation of DLX3 expression in MLL-AF4 childhood lymphoblastic leukemias is mediated by promoter region hypermethylation.
Campo Dell'Orto M; Banelli B; Giarin E; Accordi B; Trentin L; Romani M; te Kronnie G; Basso G
Oncol Rep; 2007 Aug; 18(2):417-23. PubMed ID: 17611665
[TBL] [Abstract][Full Text] [Related]
51. Gene Expression Network and Circ_0008012 Promote Progression in MLL/AF4 Positive Acute Lymphoblastic Leukemia.
Tang YL; Su JY; Luo JS; Zhang LD; Zheng LM; Liang C; Wang LN; Li Y; Fan Z; Huang DP; Sun P; Luo Z; Qi NH; Lan JJ; Zhang XL; Huang LB; Luo XQ
Recent Pat Anticancer Drug Discov; 2023; 18(4):538-548. PubMed ID: 36503469
[TBL] [Abstract][Full Text] [Related]
52. Potent obatoclax cytotoxicity and activation of triple death mode killing across infant acute lymphoblastic leukemia.
Urtishak KA; Edwards AY; Wang LS; Hudome A; Robinson BW; Barrett JS; Cao K; Cory L; Moore JS; Bantly AD; Yu QC; Chen IM; Atlas SR; Willman CL; Kundu M; Carroll AJ; Heerema NA; Devidas M; Hilden JM; Dreyer ZE; Hunger SP; Reaman GH; Felix CA
Blood; 2013 Apr; 121(14):2689-703. PubMed ID: 23393050
[TBL] [Abstract][Full Text] [Related]
53. B-cell development in the presence of the MLL/AF4 oncoprotein proceeds in the absence of HOX A7 and HOX A9 expression.
Bertrand FE; Spengeman JD; Shah N; LeBien TW
Leukemia; 2003 Dec; 17(12):2454-9. PubMed ID: 14562113
[TBL] [Abstract][Full Text] [Related]
54. Activity of immunoproteasome inhibitor ONX-0914 in acute lymphoblastic leukemia expressing MLL-AF4 fusion protein.
Jenkins TW; Downey-Kopyscinski SL; Fields JL; Rahme GJ; Colley WC; Israel MA; Maksimenko AV; Fiering SN; Kisselev AF
Sci Rep; 2021 May; 11(1):10883. PubMed ID: 34035431
[TBL] [Abstract][Full Text] [Related]
55. Epigenetic regulator genes direct lineage switching in MLL/AF4 leukemia.
Tirtakusuma R; Szoltysek K; Milne P; Grinev VV; Ptasinska A; Chin PS; Meyer C; Nakjang S; Hehir-Kwa JY; Williamson D; Cauchy P; Keane P; Assi SA; Ashtiani M; Kellaway SG; Imperato MR; Vogiatzi F; Schweighart EK; Lin S; Wunderlich M; Stutterheim J; Komkov A; Zerkalenkova E; Evans P; McNeill H; Elder A; Martinez-Soria N; Fordham SE; Shi Y; Russell LJ; Pal D; Smith A; Kingsbury Z; Becq J; Eckert C; Haas OA; Carey P; Bailey S; Skinner R; Miakova N; Collin M; Bigley V; Haniffa M; Marschalek R; Harrison CJ; Cargo CA; Schewe D; Olshanskaya Y; Thirman MJ; Cockerill PN; Mulloy JC; Blair HJ; Vormoor J; Allan JM; Bonifer C; Heidenreich O; Bomken S
Blood; 2022 Oct; 140(17):1875-1890. PubMed ID: 35839448
[TBL] [Abstract][Full Text] [Related]
56. MLL-AF4 binds directly to a BCL-2 specific enhancer and modulates H3K27 acetylation.
Godfrey L; Kerry J; Thorne R; Repapi E; Davies JO; Tapia M; Ballabio E; Hughes JR; Geng H; Konopleva M; Milne TA
Exp Hematol; 2017 Mar; 47():64-75. PubMed ID: 27856324
[TBL] [Abstract][Full Text] [Related]
57. A novel infant acute lymphoblastic leukemia cell line with MLL-AF5q31 fusion transcript.
Imamura T; Morimoto A; Ikushima S; Kakazu N; Hada S; Tabata Y; Yagi T; Inaba T; Hibi S; Sugimoto T; Imashuku S
Leukemia; 2002 Nov; 16(11):2302-8. PubMed ID: 12399976
[TBL] [Abstract][Full Text] [Related]
58. The RNA-binding protein IGF2BP3 is critical for MLL-AF4-mediated leukemogenesis.
Tran TM; Philipp J; Bassi JS; Nibber N; Draper JM; Lin TL; Palanichamy JK; Jaiswal AK; Silva O; Paing M; King J; Katzman S; Sanford JR; Rao DS
Leukemia; 2022 Jan; 36(1):68-79. PubMed ID: 34321607
[TBL] [Abstract][Full Text] [Related]
59. Inhibition of MEK and ATR is effective in a B-cell acute lymphoblastic leukemia model driven by
Chu SH; Song EJ; Chabon JR; Minehart J; Matovina CN; Makofske JL; Frank ES; Ross K; Koche RP; Feng Z; Xu H; Krivtsov A; Nussenzweig A; Armstrong SA
Blood Adv; 2018 Oct; 2(19):2478-2490. PubMed ID: 30266823
[TBL] [Abstract][Full Text] [Related]
60. Resistance of t(4;11) (MLL-AF4 fusion gene) leukemias to stress-induced cell death: possible mechanism for extensive extramedullary accumulation of cells and poor prognosis.
Kersey JH; Wang D; Oberto M
Leukemia; 1998 Oct; 12(10):1561-4. PubMed ID: 9766500
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
